Pharmaceuticals major Wockhardt on Tuesday said that it plans to restructure US business to save $12 million of annual expenses. The restructuring entails shutting down the company's manufacturing facility at Morton Grove (MGP Chicago - Illinois) and handing off the manufacturing of a few high-margin products to third parties. At 11 am, its stock traded higher by 3.5% on NSE.